Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're comparing Mounjaro bundle prices across UK providers, the honest answer is this: private tirzepatide treatment is priced per pen or per month, and the range is wide. Since Eli Lilly raised UK list prices in September 2025, reported private prices run from roughly £149 to £375 per month depending on dose and provider. But bundle pricing is where the real variation hides — and the headline figure rarely tells the full story. Mounjaro is a prescription-only medicine, so any legitimate bundle must include a clinical assessment by a qualified prescriber; without that, what you're buying isn't a bargain.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's payday Friday and you've spotted a Mounjaro bundle that looks noticeably cheaper than anything else. The listing says it includes a two- or three-month supply. The price per pen works out attractively low. You're about to enter your card details.
Stop for a moment and ask what that price actually covers. Many bundle listings are medicine-only figures. The consultation sits behind a separate fee. The prescription is billed on top. Delivery (sometimes refrigerated, always tracked) adds more. Some providers charge for dose-review support when you move from 2.5mg upward, which is a clinical step that should be supervised. If aftercare costs extra, that's not a bundle; that's an itemised bill with one line missing.
The true cost of a Mounjaro bundle is the sum of everything you need to treat safely: clinical assessment, prescription, medicine, delivery and ongoing support. A price that excludes two or three of those items isn't a bundle at all.
Eli Lilly's September 2025 list price revision changed the landscape significantly. Before that date, the highest-dose pen carried a list price of around £122; after it, that rose to roughly £330. Private providers set their own retail prices above list, so the range across the market is genuinely wide, as this overview of UK Mounjaro pricing sets out.
Dose is the biggest driver. A starter 2.5mg course costs considerably less than a 10mg or 15mg supply. That's not unusual, it reflects the medicine's licensed titration schedule, which begins at a lower dose to let your body adjust before the prescriber moves you up. What matters for comparison is the price at the dose you're likely to reach at six months, not the introductory figure.
Provider type matters too. Some services operate without a dedicated pharmacy team; dispensing happens through a third party with no ongoing clinical relationship. Others build aftercare into the price. Mounjaro's UK private price is affected by all of these, which is why comparing headline bundle figures, rather than the full cost of a safe course of treatment, rarely leads to the right decision.
We'll say it plainly: we are not the cheapest option in this market, and that's a deliberate choice. What the price at nume covers is the full picture: consultation, prescription, medicine, free next-working-day DPD delivery and clinical aftercare, seven days a week. No subscription. No auto-renewal. Every repeat order goes back in front of a prescriber (a named, GPhC-registered Independent Prescriber, not a decision algorithm) before anything is dispensed.
Our pharmacy holds GPhC premises registration 9012878, verifiable on the GPhC register, and medicines are sourced through the licensed UK supply chain. If you order before 12pm Monday to Friday and your consultation is approved that day, your treatment goes out with DPD the same afternoon. If spreading the cost would make starting treatment easier, you can also find out more about getting your Mounjaro injection on a buy now pay later basis. Current treatment pricing is shown on our consultation and treatment page.
More detail on how the individual elements fit together is on our Mounjaro bundle pricing page. If you have questions before you start, the FAQs cover most of the common ones.
Tirzepatide (the active medicine in Mounjaro) is a prescription-only medicine under UK law. That means it can only be legally supplied following a clinical assessment by a qualified prescriber. The MHRA has issued repeated warnings about counterfeit weight-loss pens sold without a prescription online and via social media; some contained insulin rather than the stated medicine. Enforcement in 2025 led to seizures of around 20 million doses of illegally traded weight-loss medicines and the first UK raid on a counterfeit tirzepatide manufacturing site.
Red flags to watch for: prices well below the market range described above, sellers offering Mounjaro without a full clinical consultation, or any bundle offered without a verifiable GPhC-registered pharmacy behind it. You can check any UK online pharmacy on the GPhC register in under a minute. If a provider isn't listed there, that's your answer.
A small saving per pen is not worth the risk of receiving a counterfeit medicine with no clinical oversight. What makes a bundle genuinely good value is safety, clinical support and legitimate supply, and that's the test worth applying.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.